Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.47 |
| ▸ | CNR1 | P21554 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.39 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.39 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.39 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL999133 | 1.00 | CNR2 (0.47) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL997432 | 1.00 | CNR2 (0.47) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL996038 | 1.00 | CNR2 (0.47) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL995956 | 1.00 | CNR2 (0.47) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL996906 | 1.00 | CNR2 (0.47) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL995583 | 1.00 | CNR2 (0.47) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL996264 | 0.91 | DNM1 (0.48) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL999453 | 0.91 | DNM1 (0.48) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL995955 | 0.91 | DNM1 (0.48) | CNR2CNR1ALDH1A1DNM1LPAR1 | |
| SCHEMBL995593 | 0.91 | DNM1 (0.48) | CNR2CNR1ALDH1A1DNM1LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2454233-B1 | SULFONATE SURFACTANTS AND METHODS FOR THEIR PREPARATION AND USE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-02-25 | — | — | EP | disclosed |
| US-8304377-B2 | Sulfonate surfactants and methods of preparation and use | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-11-06 | — | — | US | disclosed |
| EP-2454233-A2 | SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE | Dow Global Technologies LLC (US) | 2012-05-23 | — | — | EP | disclosed |
| US-20110015111-A1 | SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE | DCOMCO, INC. | 2011-01-20 | — | — | US | disclosed |
| WO-2011008570-A2 | SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2011-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015111-A1 | SULFONATE SURFACTANTS AND METHODS OF PREPARATION AND USE | STS, SRR, SGMS1 | CNR2 394/4885CNR1 95/4885ALDH1A1 3530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.